Alexis C. Geppner, MLS, CTTS, MPAS, PA-C @AGeppnerPAC profile

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

Followers

132

Following

128

Statuses

30

Physician Assistant- Department of Leukemia- UT MD Anderson Cancer Center. All opinions are my own.

Houston, TX

Joined November 2018

Don't wanna be here? Send us removal request.

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

3 years

1 in 3 Americans have skipped medicine because of the cost. President Biden: Act now

0

2

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

3 years

RT @BNODesk: Omicron subvariant BA.2 appears to have a substantial growth advantage over BA.1, UK health agency says

0

1K

0

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

@maitkencancerhx Haha thanks Reese! #nerdycostumes all the way!

0

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

Great discussion at #JADPROLive on #womeninoncology. @APSHOorg @JADPRO

1

4

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

If you haven't already, make sure to stop by the poster hall at #JADPROLive @APSHOorg to see the excellent work and collaboration APs are doing around the country! @JADPRO

0

2

7

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

Greatly appreciate Lorena Alarcon-Casas Wright, MD, FACE for the discussion on the management of diabetes in patients with cancer at #JADPROLive. Looking forward to sharing the knowledge with my colleagues. @APSHOorg @JADPRO

1

5

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

@PoonamG59798281 I ask because I've read that you place your most prestigious accomplishment first in some literature and last in other literature.

0

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

Cardio-Oncology: The Intersection of Cardiovascular Disease and Cancer. An important topic to discuss at #JADPROLive tomorrow that impacts all of our patients. @APSHOorg @JADPRO

0

1

2

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

Excellent discussion on the topic of career ladders for APs at #JADPROLive @APSHOorg @JADPRO

0

2

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

JADPRO Live 2020 - Venetoclax AML Patient Management. Looking forward to this presentation at #JADPROLive @APSHOorg @JADPRO

0

3

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

Check out this discussion on the topic of career ladders for APPs!

0

1

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

@kristin_daly @APSHOorg @JADPRO That was really fun! Thank you 😅

0

1

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

@GretchenMcnally @APSHOorg Haha thank you so much 😆

0

1

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

Lots of fun things going on at #JADPROLive !

APSHO

@APSHOorg

4 years

We're looking forward to connecting with you on our social media during #JADPROLive. To kick things off, how about some prizes! Just follow us, 'like' this post, and head to to enter. You could win a $100 or $50 amazon gift card!

0

1

2

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

@allydprice <3

0

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

Check out this post by @JADPRO on My social wall via @walls_io

APSHO

@APSHOorg

4 years

Things are looking a little different in the #JADPROLive staff room this year. Are you watching the sessions with colleagues? Let's see your #SociallyDistanced setup and #APSHO masks! #WearAMask

0

1

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

Interesting to learn the roles APs have in the FDA.

JADPRO

@JADPRO

4 years

Dr. Richard Pazdur, Director of the FDA’s Oncology Center of Excellence (OCE) joins us @JADPROLive Virtual to share recent changes in drug development and approval, the role of the #AP in #clinicaltrials and changes resulting from #COVID19

0

5

Alexis C. Geppner, MLS, CTTS, MPAS, PA-C

@AGeppnerPAC

4 years

RT @JADPRO: Looking for #DrugUpdates in #hematology? They're coming soon! Mark your schedule for Thursday October 22 at 2:45pm ET. See you…

0

1

0